Synthetic biology funds back companies programming biology to create new materials, medicines, and chemicals. From engineered microbes to cell-free systems, these investors fuel the transition from petrochemical to biological manufacturing.
27 funds
Menlo Park, United States
Chicago, United States
Brooklyn, United States
United States
Copenhagen, Denmark
Zurich, Switzerland
San Francisco, United States
London, United Kingdom
Cambridge, United States
Buenos Aires, Argentina
San Diego, United States
United States
United States
Rio de Janeiro, Brazil
Auckland, New Zealand
Boston, United States
United States
Berlin, Germany
London, United Kingdom
New York, United States